home / stock / prph / prph news


PRPH News and Press, ProPhase Labs Inc. From 03/14/24

Stock Information

Company Name: ProPhase Labs Inc.
Stock Symbol: PRPH
Market: NASDAQ
Website: prophaselabs.com

Menu

PRPH PRPH Quote PRPH Short PRPH News PRPH Articles PRPH Message Board
Get PRPH Alerts

News, Short Squeeze, Breakout and More Instantly...

PRPH - Notable earnings before Friday's open

2024-03-14 10:09:45 ET Major earnings expected before the bell on Friday include: The Buckle ( BKE ) EHang Holdings ( EH ) Groupon ( GRPN ) Jabil ( JBL ) Seanergy Maritime Holdings ( SHIP ) Read the full article on Seeking Alpha For fu...

PRPH - PROPHASE LABS TO PRESENT 2023 YEAR END FINANCIAL RESULTS ON MARCH 15, 2024

GARDEN CITY, NY, March 08, 2024 (GLOBE NEWSWIRE) -- ProPhase Labs Inc. (NASDAQ: PRPH), announced today that they will be presenting full year 2023 financial results on a virtual conference call hosted by Renmark Financial on March 15, 2024 at 11:00 am EDT. ProPhase Labs Inc. welcomes stakeholde...

PRPH - Diamond Equity Research Releases Update Note on ProPhase Labs Inc. (NASDAQ: PRPH)

NEW YORK, Feb. 21, 2024 (GLOBE NEWSWIRE) -- Diamond Equity Research, a leading equity research firm with a focus on small capitalization public companies has released an Update Note on ProPhase Labs Inc. (NASDAQ: PRPH). The update note includes information on the ProPhase’s business model,...

PRPH - ProPhase Labs Announces Significant Progress in BE-Smart Esophageal Cancer Test Development USPTO grants additional broad patents for BE-SMART

Garden City, NY, Feb. 20, 2024 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH), a next generation biotech, genomics and diagnostics company, today announced important developments in the Company’s efforts to commercialize its novel BE-SMART esophageal cancer...

PRPH - ProPhase Labs Announces Preliminary Positive Results for Dietary Supplement Equivir

Commercialization of Equivir anticipated after second trial is completed in Q2, 2024 Garden City, NY, Feb. 14, 2024 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH), a next generation biotech, genomics and diagnostics company, today announced positive prelimin...

PRPH - Diamond Equity Research Releases In Depth Update Note on ProPhase Labs, Inc. (NASDAQ: PRPH) subsidiary, Pharmaloz Manufacturing, Inc. (PMI)

NEW YORK, Feb. 08, 2024 (GLOBE NEWSWIRE) -- Diamond Equity Research, a leading equity research firm with a focus on small capitalization public companies has released Company Research Report on Pharmaloz Manufacturing Inc., a wholly owned subsidiary of ProPhase Labs Inc. (NASDAQ: PRPH). The in-de...

PRPH - ProPhase Labs Ushers in New Genomics Era with Jason Karkus at the Helm of Nebula Genomics

Garden City, NY, Jan. 30, 2024 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH) (“ProPhase” or the “Company”), a next generation biotech, genomics, therapeutics and diagnostics company, today reported that Jason Karkus, one of the dr...

PRPH - ProPhase Labs eyes higher revenue for lozenge-making unit with improved pricing

2024-01-23 09:11:39 ET More on ProPhase Labs ProPhase Labs, Inc. (PRPH) Q3 2023 Earnings Call Transcript Seeking Alpha’s Quant Rating on ProPhase Labs Historical earnings data for ProPhase Labs Financial information for ProPhase Labs Read the...

PRPH - Pharmaloz Manufacturing Accelerates Expansion, Improves Pricing, Boosts Profitability and Secures New Contracts

Pharmaloz Wins Two New Contracts in January that are Anticipated to Significantly Increase Lozenge Revenues and Profitability Company in Late-Stage Discussions with Two Additional Large Global Brands Which, if Consummated, Could more than Triple Run-Rate of Revenues Before Year-End 2024 ...

PRPH - ProPhase hires Jed Latkin as COO

2024-01-04 10:19:21 ET More on ProPhase Labs ProPhase Labs, Inc. (PRPH) Q3 2023 Earnings Call Transcript Seeking Alpha’s Quant Rating on ProPhase Labs Historical earnings data for ProPhase Labs Financial information for ProPhase Labs For furthe...

Previous 10 Next 10